These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6945100)

  • 21. Adderall, the atypicals, and weight gain.
    Horrigan JP; Barnhill LJ; Kohli RR
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):620. PubMed ID: 11392337
    [No Abstract]   [Full Text] [Related]  

  • 22. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder.
    Wilens TE; Waxmonsky J; Scott M; Swezey A; Kwon A; Spencer TJ; Biederman J
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):947-55. PubMed ID: 16379515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MBD children--variability in developmental patterns or growth inhibitory effect of stimulants?
    Kaffman M; Sher A; Bar-Sinai N
    Isr Ann Psychiatr Relat Discip; 1979 Mar; 17(1):58-66. PubMed ID: 287660
    [No Abstract]   [Full Text] [Related]  

  • 24. [The diagnosis and treatment of the attention deficit syndrome in children].
    Zavadenko NN; Uspenskaia TIu; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(1):57-61. PubMed ID: 9163252
    [No Abstract]   [Full Text] [Related]  

  • 25. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.
    Weiss MD; Gibbins C; Goodman DW; Hodgkins PS; Landgraf JM; Faraone SV
    J Clin Psychiatry; 2010 Apr; 71(4):381-90. PubMed ID: 20361900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of Aponeuron in the treatment of children with hyperkinetic syndrome].
    Paclt I; Florian J; Brunclíková J; Růzicková I
    Ceska Slov Psychiatr; 1996 May; 92 Suppl 1():41-57. PubMed ID: 8768943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology.
    Faraone SV; Pliszka SR; Olvera RL; Skolnik R; Biederman J
    J Child Adolesc Psychopharmacol; 2001; 11(2):171-80. PubMed ID: 11436957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD].
    Ludolph AG; Kölch M; Plener PL; Schulze UM; Spröber N; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):405-11. PubMed ID: 19739058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperactivity.
    Poole SR
    Prim Care; 1984 Sep; 11(3):431-42. PubMed ID: 6567216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A washout period needed before switching from a neuroleptic to an amphetamine.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention deficit hyperactivity disorder in adults.
    Rösler M; Casas M; Konofal E; Buitelaar J
    World J Biol Psychiatry; 2010 Aug; 11(5):684-98. PubMed ID: 20521876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Rowles BM; Findling RL
    Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G; Newcorn JH
    Pediatr Clin North Am; 2011 Feb; 58(1):99-120, xi. PubMed ID: 21281851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials.
    Surman CB; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):903-8. PubMed ID: 21824454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADHD black box warning: how concerned should we be?
    Cruz R; Kutscher EC
    S D Med; 2007 Feb; 60(2):63, 65. PubMed ID: 17390569
    [No Abstract]   [Full Text] [Related]  

  • 38. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder.
    Van Brunt DL; Johnston JA; Ye W; Pohl GM; Sun PJ; Sterling KL; Davis ME
    Pharmacotherapy; 2005 Nov; 25(11):1541-9. PubMed ID: 16232017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.
    Grcevich S; Rowane WA; Marcellino B; Sullivan-Hurst S
    J Child Adolesc Psychopharmacol; 2001; 11(1):35-41. PubMed ID: 11322743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.